Last reviewed · How we verify

NCT03404128

Long Term Follow-up of Hippocampal DBS for Refractory Epilepsy

Completed Last updated 18 August 2021
What this trial tests

trial testing Questionnaires in Refractory Epilepsy in 6 participants. Completed in 20 April 2021.

Timeline
11 January 2016
Primary endpoint
20 April 2021
20 April 2021

Quick facts

Lead sponsorUniversity Hospital, Ghent
StatusCompleted
Study typeOBSERVATIONAL
Enrollment6
Start date11 January 2016
Primary completion20 April 2021
Estimated completion20 April 2021

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Ghent

Who can join

Eligibility, any sex, with Refractory Epilepsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Follow up of the patients at Ghent University Hospital treated with hippocampal DBS for refractory epilepsy. Endpoints: * Long term evaluation of the effects of hippocampal DBS on seizure frequency and cognition * Evaluation of the satisfaction of patients and neurologist regarding the rechargeable DBS battery

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Deep Brain Stimulation for the Management of Refractory Neurological Disorders: A Comprehensive Review.
    Rissardo JP, Vora NM, Tariq I, Mujtaba A, et al · · 2023 · cited 17× · PMID 38004040 · DOI 10.3390/medicina59111991
  2. Clinical Trials Examining Deep Brain Stimulation for the Treatment of Epilepsy: An Analysis of the Current State.
    Gould J, Patel S, Chaurasia B. · · 2025 · PMID 41446446 · DOI 10.7759/cureus.97571

Verify or expand the search:

Other trials of Questionnaires

Trials testing the same drug.

Other recruiting trials for Refractory Epilepsy

Currently open trials in the same condition.

Other University Hospital, Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03404128.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing